ZENTEK LTD (ZEN.CA) Stock Fundamental Analysis
Canada - TSX-V:ZEN - CA98942X1024 - Common Stock
1.08 CAD
0 (0%)
ZEN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Equipment & Supplies industry. The financial health of ZEN is average, but there are quite some concerns on its profitability. ZEN is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ZEN had negative earnings in the past year.
ZEN had a negative operating cash flow in the past year.
In the past 5 years ZEN always reported negative net income.
In the past 5 years ZEN always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -47.88%, ZEN is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
ZEN has a Return On Equity of -63.26%. This is amongst the best in the industry. ZEN outperforms 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.88% | ||
| ROE | -63.26% | ||
| ROIC | N/A |
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ZEN has a worse Gross Margin (24.60%) than 66.67% of its industry peers.
ZEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.6% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ZEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZEN has more shares outstanding
Compared to 5 years ago, ZEN has more shares outstanding
Compared to 1 year ago, ZEN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 7.28 indicates that ZEN is not in any danger for bankruptcy at the moment.
ZEN has a Altman-Z score of 7.28. This is amongst the best in the industry. ZEN outperforms 100.00% of its industry peers.
ZEN has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.12, ZEN is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 7.28 |
ROIC/WACCN/A
WACC7.83%
2.3 Liquidity
ZEN has a Current Ratio of 1.62. This is a normal value and indicates that ZEN is financially healthy and should not expect problems in meeting its short term obligations.
ZEN has a Current ratio of 1.62. This is amongst the best in the industry. ZEN outperforms 86.67% of its industry peers.
A Quick Ratio of 1.30 indicates that ZEN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.30, ZEN belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
ZEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.39%, which is quite impressive.
The Revenue has grown by 2519.83% in the past year. This is a very strong growth!
The Revenue has been growing by 35.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.62%
Revenue 1Y (TTM)2519.83%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%950.91%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ZEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ZEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:ZEN (11/17/2025, 7:00:00 PM)
1.08
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.47%
Inst Owner ChangeN/A
Ins Owners1.2%
Ins Owner ChangeN/A
Market Cap113.23M
Revenue(TTM)924.80K
Net Income(TTM)-8.85M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 122.43 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 8.09 | ||
| P/tB | 8.09 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.01
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.88% | ||
| ROE | -63.26% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.6% | ||
| FCFM | N/A |
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 35.19% | ||
| Cap/Sales | 22.13% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 7.28 |
F-Score4
WACC7.83%
ROIC/WACCN/A
Cap/Depr(3y)182.79%
Cap/Depr(5y)454.82%
Cap/Sales(3y)1708.52%
Cap/Sales(5y)12638%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2519.83%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%950.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.21%
OCF growth 3YN/A
OCF growth 5YN/A
ZENTEK LTD / ZEN.CA FAQ
Can you provide the ChartMill fundamental rating for ZENTEK LTD?
ChartMill assigns a fundamental rating of 3 / 10 to ZEN.CA.
What is the valuation status for ZEN stock?
ChartMill assigns a valuation rating of 0 / 10 to ZENTEK LTD (ZEN.CA). This can be considered as Overvalued.
Can you provide the profitability details for ZENTEK LTD?
ZENTEK LTD (ZEN.CA) has a profitability rating of 1 / 10.